FDA Investigator Kristin M Abaonza

Kristin M Abaonza has conducted inspections on 95 sites in 6 countries as of 27 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
95
Last Inspection Date:
27 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Korea (Republic of), United Kingdom of Great Britain and Northern Ireland, Canada, Belgium, Poland
FDA Investigators that have inspected at least one site in common with Kristin M Abaonza:
Adam S Freeman, Addam S Reynolds, Alan L Truong, Alexander M Kay, Alla Dubrovsky, Allen F Hall, Amogh Pathi, Anastasia I Onuorah, Andrew B Slarve, Andrew E Kay, Andrew T Todd, Angel K Sandhu, Angela Shepas, Anh M Lac, Anita Narula, PhD, Ann M Stewart, Anna J Vickrey, Annie H Lam, Anthony E Keller, RPh, Antionette N Johnson, Arindam Dasgupta, PhD, Ashar P Parikh, Astrida B Mattson, Barbara A Crowl, Barbara Janine Breithaupt, Binh T Nguyen, Bo Chi, PhD, Bradley Dworak, PhD, Brandon Bridgman, Carl Lee, Carolina D Vasquez, Caryn M Mcnab, CDR Rochelle B Young, RPh, MSA, Chiang Syin, PhD, Chloe Anne Leong, Christian D Lynch (CDL), Christine A Harman, PhD, Christine M Parmentier, Christopher Do, Christopher M Jenner, Christopher R Czajka, Christopher W Buser, Cindy W Lewis, Concepcion Cruz, Jr, Connie P Rezendes, Courtney R Bolton, Crystal Monroy, Cynthia J Lee, MS, Cynthia J Tsui, Cynthia L Ford, Damon A Growl, Daniel J Roberts, Darren S Brown, David G Eng, Dawn E Barkans, Deborah A Nebenzahl, Debra D Devlieger, Debra Lboyd Seale, Dena L Jacobs, Diane Cvan Leeuwen, Diane L Raccasi, Diane R Weidley, Dogbeda F Mackenzie, Dolores E Price, Don H Bark, PhD, Douglas A Campbell, Dr. Chunchang Fang, Dr. Ralph M Bernstein, PhD, Dustin P Tran, Dustin R Abaonza, Edna J Hidalgo, Edwin Melendez, Eileen A Liu, Elizabeth A Dakan, Elodie X Tong Lin, Emmanuel O Kerry, Ephrem Hunde, PhD, Eric J Heinze, Eric W Anderson, Erica R Pomeroy, Estefania Fernandez, Farwa Z Razvi, Gabrielle J Swain, Gary R Wong, Gerald N Mcgirl, DDS, Gerard Pde Leon, Gloria J Baca, MS, Hao Kiet D Phan, Haoheng Yan, PhD, Heidy C Perales, Heika R Bounds, Heika R Tait, Henry K Lau, Hugh M Mcclure, II, Hung H Do, MS, Huy T Pham, Hyung Yul Lee, Jacek Cieslak, PhD, Jacob G Lutz, Jacqueline Mdiaz Albertini, James A Lane, James B Arnett, James P Mcreavey, Janet L Bowen, Jannifer L Degroot, Jasmine Y Wang, Jazmine M Welcher, Jeanmaire Hryshko, Jeanne J Thai, Jeffrey J Leclair, Jeffrey M Watson, Jeffrey P Raimondi, Jeffrey S Buckser, Jeffrey W Shrifter, DPM, Jennifer Crumb, Jennifer L Bridgewater, Jennifer L Degroot, Jennifer L Johnson, Jennifer M Gogley, Jessica L Pressley, Jie He, Joan M Cantellops Figueroa, Joanne M Fukuda, Jocelyn T Ramos, Joey V Quitania, John A Gonzalez, Jolanna A Norton, Jolene S Hedgecock, Jose Martinez, Jr, Joshua P Wireman, Jude C Dikes, Junho Pak, Justin A Boyd, Kacie M Crowther, Kaitlyn T Dang, Karen D Phung, Kari M Johansen, Katherine D Adams, Kathryn A Krentz, Kawshalya Pathiraja, Keeshunna D Daniels, Kelley, Kellia N Hicks, Kelvin Cheung, Kelvin X Sanders, Kenneth O Gee, PhD, Kenya Destin, Keren Arkin, Kevin P Foley, Kim Lthomas Cruse, Kurt A Brorson, PhD, Lakecha N Lewis, Lan T Tran, Lance A Finnical, Lance Mde Souza, MBA, Latorie S Jones, Laurel A Beer, Lawton W Lum, LCDR Debra Emerson, LCDR Jennifer H Rhyu, Libia M Lugo, Lija V Fellows, Linda S Shook, Linh Tu, Lisa K Capron, Lopez, Lorraine N Williams, Lourdes Andujar, LT Mark A Chen, MPH, Lucila B Nwatu, Lynda L Perry, PhD, Mabel M Lee, Maida Henesian (NMI), Marcus F Yambot, Maria Cruz Fisher, Maria Pkelly Doggett, MBA, Marie K Kinkade, Marijo B Kambere, PhD, Mariza M Jafary, Mark E Chan, Mark E Parmon, Mark W Babbitt, Marlo Ianm Alintanahin, Marshalette O Edwards, Mary R Hole, Marybet Lopez Negron, Matthew B Casale, Matthew D Schnittker, Matthew M Vernon, Maxine H Wong, Megan E Kulas, Melanie M Walker, Michael D Garcia, Michael R Klapal, Michelle Yclark Stuart, Mihaly S Ligmond, Mikel T Wright, Monica Commerford, PhD, Monica E Caphart, Monique C Lo, Myra K Casey, Natalie J Ayoub, Nicholas L Hunt, Nympha V Florendo, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Patsy J Domingo, Paul L Figarole, Jr, Paula A Trost, Peter Adams, PhD, Peter E Baker, Phillip M Pontikos, Phung, Prabhu P Raju, Quynh H Strandberg, Randy L Self, Raymond T Oji, Rebecca E Dombrowski, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Robert D Tollefsen, Robert J Martin, Robert S Sweeton, Robles, Roger D Gawne, Ronald P Boyce, Rumany C Penn, PharmD, Russell J Glapion, Ryan J Borges, S Lori Brown, PhD MPH, Saleem A Akhtar, Samantha J Bradley, Sandra S Saniga, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sara H Gabel, Savannah E Samp, Scott B Laufenberg, Scott N Lim, Sergio Chavez (NMI), Shaquenta Y Perkins, Sharon K Thoma, PharmD, Shelby N Turner, Shelley H Beausoleil, Sherri N Rohlf, MD, Stacie A Woods, Stephanie A Slater, MS, Stephen D Eich, Steven B Chiu, Steven M Galvez, Stuart W Russell, Sundy V Sedwick, Susan F Laska, MS, Susanna E Ford, Suzanne M Crotty, Tamala P Bogan, Tamala P Magee, Terrence Gee, Terri L Dodds, Thao T Kwan, Thea C Grome, Thomas J Arista, Thomas N Adjabeng, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Grome, Tina S Roecklein, Tracy Denison, PhD, Tracy K Li, Uduak M Inokon, Uttaniti Limchumroon (Tom), Vaishali J Patel, Vibhakar J Shah, PhD, Viviana Matta, Walden H Lee, Wayne E Seifert, Wayne L Jefferson, Wen Jun Peng, William V Millar, Xiomara Copeland, Yen Tso Kuo, Yong Hu, Yumi J Hiramine, Yvonne T Lacour, Zachary A Bogorad, Zhong Li, PhD

Kristin M Abaonza's Documents

Publish Date Document Type Title
July, 2019 EIR Jubilant HollisterStier LLC - EIR, 2019-07-26
April, 2022 FDA 483 Omid Tehrani, M.D. - Form 483, 2022-04-14
September, 2018 FDA 483 White House Pharmacy Inc. dba San Jose Compounding Pharmacy - Form 483, 2018-09-14
June, 2023 FDA 483 Neuralink Corporation - Form 483, 2023-06-22
September, 2020 FDA 483 Daniel Norman, M.D. - Form 483, 2020-09-02
August, 2019 FDA 483 Resilience Biotechnologies, Inc. - Form 483, 2019-08-28
November, 2018 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2018-12-07
April, 2015 FDA 483 VitaSea Products Int'l , Inc. dba Wachters' Organic Sea Products - Form 483, 2015-04-17
March, 2019 FDA 483 Response MOM Enterprises, Inc. - Form 483R, 2019-04-09
March, 2022 EIR SanBio, Inc. - EIR, 2022-03-04
April, 2019 FDA 483 Geneva Woods Pharmacy Inc - Form 483, 2019-04-16
July, 2017 FDA 483 One Way Drug, LLC - Form 483, 2017-07-19
March, 2017 EIR G.S. COSMECEUTICAL USA, INC. - EIR, 2017-03-16
October, 2019 FDA 483 TriReme Medical, LLC. - Form 483, 2019-10-30
October, 2020 FDA 483 Paul Harmatz, M.D. - Form 483, 2020-10-16
March, 2019 FDA 483 Citragen Pharmaceuticals Inc - Form 483, 2019-03-05
November, 2017 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2017-11-09
December, 2018 FDA 483 Element Materials Technology Oakland - Concord Inc. - Form 483, 2018-12-21
March, 2024 FDA 483 CymaBay Therapeutics, Inc. - Form 483, 2024-03-20
July, 2018 EIR CELLTRION Inc - EIR, 2018-07-17
November, 2020 EIR Paul Harmatz, M.D. - EIR, 2020-11-05
July, 2019 FDA 483 Vanton Research Laboratory, LLC - Form 483, 2019-07-02
March, 2019 FDA 483 MOM Enterprises, Inc. - Form 483, 2019-03-20
February, 2020 FDA 483 Hessam Aazami, M.D. - Form 483, 2020-02-04
July, 2019 FDA 483 Jubilant HollisterStier LLC - Form 483, 2019-07-26
April, 2017 FDA 483 Boehringer Ingelheim Fremont, Inc. - Form 483, 2017-04-04
December, 2022 FDA 483 Anish Shah, M.D. - Form 483, 2022-12-16
March, 2016 FDA 483 Reliable Rexall-A Compounding Pharmacy - Form 483, 2016-04-20
December, 2021 FDA 483 Daniel Fred Goodman, M.D. - Form 483, 2021-12-13
November, 2018 FDA 483 Response SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483R, 2018-12-10
November, 2018 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2018-11-16
December, 2018 EIR Element Materials Technology Oakland - Concord Inc. - EIR, 2018-12-21
July, 2018 FDA 483 CELLTRION Inc - Form 483, 2018-07-17
March, 2023 FDA 483 Fred K. Kurata, M.D. - Form 483, 2023-03-30
November, 2016 FDA 483 Assertio Therapeutics, Inc. - Form 483, 2016-11-02
April, 2019 EIR ASEGUA THERAPEUTICS LLC - EIR, 2019-04-04
March, 2018 FDA 483 Product Packaging West, Inc. - Form 483, 2018-03-13
October, 2017 FDA 483 Allure Labs, Inc - Form 483, 2017-10-25
May, 2023 FDA 483 LimFlow, Inc. - Form 483, 2023-05-15
January, 2024 FDA 483 Element Science, Inc. - Form 483, 2024-01-22
July, 2015 EIR 9 ayer Healthcare LLC - EIR, 2015-06-30
June, 2021 FDA 483 Santa Clara Valley Medical Center IRB - Form 483, 2021-06-03
June, 2016 EIR Harmony Foods, LLC. dba SCN BestCo - EIR, 2016-06-09
May, 2024 FDA 483 Maps Public Benefit Corporation - Form 483, 2024-05-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more